BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Español A, Salem A, Sanchez Y, Sales ME. Breast cancer: Muscarinic receptors as new targets for tumor therapy. World J Clin Oncol 2021; 12(6): 404-428 [PMID: 34189066 DOI: 10.5306/wjco.v12.i6.404]
URL: https://www.wjgnet.com/2218-4333/full/v12/i6/404.htm
Number Citing Articles
1
Zhiguo Wang, Baofeng Yang. Polypharmacology2022; : 73 doi: 10.1007/978-3-031-04998-9_3
2
Joshua D. Bernstock, Jakob V. E. Gerstl, Jason A. Chen, Benjamin R. Johnston, Leo F. Nonnenbroich, Lennard Spanehl, Florian A. Gessler, Pablo A. Valdes, Yi Lu, Shriya S. Srinivasan, Timothy R. Smith, Pierpaolo Peruzzi, John D. Rolston, Scellig Stone, E. Antonio Chiocca. The Case for Neurosurgical Intervention in Cancer NeuroscienceNeurosurgery 2024;  doi: 10.1227/neu.0000000000003039
3
Anastasia N. Vaganova, Daria D. Maslennikova, Valeria V. Konstantinova, Evgeny V. Kanov, Raul R. Gainetdinov. The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic SubtypeBiomolecules 2023; 13(9): 1361 doi: 10.3390/biom13091361
4
Gloria M. Calaf, Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo, Tammy C. Bleak. Muscarinic Receptors Associated with CancerCancers 2022; 14(9): 2322 doi: 10.3390/cancers14092322
5
Yamila Sanchez, Mariana Abigail Vasquez Callejas, Noelia Victoria Miret, Gabino Rolandelli, Catalina Costas, Andrea Silvana Randi, Alejandro Español. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cellsExploration of Targeted Anti-tumor Therapy 2024; 5(2): 278 doi: 10.37349/etat.2024.00218